Cargando…

Quantitation of ERK1/2 inhibitor cellular target occupancies with a reversible slow off-rate probe

Target engagement is a key concept in drug discovery and its direct measurement can provide a quantitative understanding of drug efficacy and/or toxicity. Failure to demonstrate target occupancy in relevant cells and tissues has been recognised as a contributing factor to the low success rate of cli...

Descripción completa

Detalles Bibliográficos
Autores principales: Lebraud, Honorine, Surova, Olga, Courtin, Aurélie, O'Reilly, Marc, Valenzano, Chiara R., Nordlund, Pär, Heightman, Tom D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Royal Society of Chemistry 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253716/
https://www.ncbi.nlm.nih.gov/pubmed/30568786
http://dx.doi.org/10.1039/c8sc02754d
_version_ 1783373561190154240
author Lebraud, Honorine
Surova, Olga
Courtin, Aurélie
O'Reilly, Marc
Valenzano, Chiara R.
Nordlund, Pär
Heightman, Tom D.
author_facet Lebraud, Honorine
Surova, Olga
Courtin, Aurélie
O'Reilly, Marc
Valenzano, Chiara R.
Nordlund, Pär
Heightman, Tom D.
author_sort Lebraud, Honorine
collection PubMed
description Target engagement is a key concept in drug discovery and its direct measurement can provide a quantitative understanding of drug efficacy and/or toxicity. Failure to demonstrate target occupancy in relevant cells and tissues has been recognised as a contributing factor to the low success rate of clinical drug development. Several techniques are emerging to quantify target engagement in cells; however, in situ measurements remain challenging, mainly due to technical limitations. Here, we report the development of a non-covalent clickable probe, based on SCH772984, a slow off-rate ERK1/2 inhibitor, which enabled efficient pull down of ERK1/2 protein via click reaction with tetrazine tagged agarose beads. This was used in a competition setting to measure relative target occupancy by selected ERK1/2 inhibitors. As a reference we used the cellular thermal shift assay, a label-free biophysical assay relying solely on ligand-induced thermodynamic stabilization of proteins. To validate the EC(50) values measured by both methods, the results were compared with IC(50) data for the phosphorylation of RSK, a downstream substrate of ERK1/2 used as a functional biomarker of ERK1/2 inhibition. We showed that a slow off-rate reversible probe can be used to efficiently pull down cellular proteins, significantly extending the potential of the approach beyond the need for covalent or photoaffinity warheads.
format Online
Article
Text
id pubmed-6253716
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Royal Society of Chemistry
record_format MEDLINE/PubMed
spelling pubmed-62537162018-12-19 Quantitation of ERK1/2 inhibitor cellular target occupancies with a reversible slow off-rate probe Lebraud, Honorine Surova, Olga Courtin, Aurélie O'Reilly, Marc Valenzano, Chiara R. Nordlund, Pär Heightman, Tom D. Chem Sci Chemistry Target engagement is a key concept in drug discovery and its direct measurement can provide a quantitative understanding of drug efficacy and/or toxicity. Failure to demonstrate target occupancy in relevant cells and tissues has been recognised as a contributing factor to the low success rate of clinical drug development. Several techniques are emerging to quantify target engagement in cells; however, in situ measurements remain challenging, mainly due to technical limitations. Here, we report the development of a non-covalent clickable probe, based on SCH772984, a slow off-rate ERK1/2 inhibitor, which enabled efficient pull down of ERK1/2 protein via click reaction with tetrazine tagged agarose beads. This was used in a competition setting to measure relative target occupancy by selected ERK1/2 inhibitors. As a reference we used the cellular thermal shift assay, a label-free biophysical assay relying solely on ligand-induced thermodynamic stabilization of proteins. To validate the EC(50) values measured by both methods, the results were compared with IC(50) data for the phosphorylation of RSK, a downstream substrate of ERK1/2 used as a functional biomarker of ERK1/2 inhibition. We showed that a slow off-rate reversible probe can be used to efficiently pull down cellular proteins, significantly extending the potential of the approach beyond the need for covalent or photoaffinity warheads. Royal Society of Chemistry 2018-09-17 /pmc/articles/PMC6253716/ /pubmed/30568786 http://dx.doi.org/10.1039/c8sc02754d Text en This journal is © The Royal Society of Chemistry 2018 http://creativecommons.org/licenses/by-nc/3.0/ This article is freely available. This article is licensed under a Creative Commons Attribution Non Commercial 3.0 Unported Licence (CC BY-NC 3.0)
spellingShingle Chemistry
Lebraud, Honorine
Surova, Olga
Courtin, Aurélie
O'Reilly, Marc
Valenzano, Chiara R.
Nordlund, Pär
Heightman, Tom D.
Quantitation of ERK1/2 inhibitor cellular target occupancies with a reversible slow off-rate probe
title Quantitation of ERK1/2 inhibitor cellular target occupancies with a reversible slow off-rate probe
title_full Quantitation of ERK1/2 inhibitor cellular target occupancies with a reversible slow off-rate probe
title_fullStr Quantitation of ERK1/2 inhibitor cellular target occupancies with a reversible slow off-rate probe
title_full_unstemmed Quantitation of ERK1/2 inhibitor cellular target occupancies with a reversible slow off-rate probe
title_short Quantitation of ERK1/2 inhibitor cellular target occupancies with a reversible slow off-rate probe
title_sort quantitation of erk1/2 inhibitor cellular target occupancies with a reversible slow off-rate probe
topic Chemistry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253716/
https://www.ncbi.nlm.nih.gov/pubmed/30568786
http://dx.doi.org/10.1039/c8sc02754d
work_keys_str_mv AT lebraudhonorine quantitationoferk12inhibitorcellulartargetoccupancieswithareversibleslowoffrateprobe
AT surovaolga quantitationoferk12inhibitorcellulartargetoccupancieswithareversibleslowoffrateprobe
AT courtinaurelie quantitationoferk12inhibitorcellulartargetoccupancieswithareversibleslowoffrateprobe
AT oreillymarc quantitationoferk12inhibitorcellulartargetoccupancieswithareversibleslowoffrateprobe
AT valenzanochiarar quantitationoferk12inhibitorcellulartargetoccupancieswithareversibleslowoffrateprobe
AT nordlundpar quantitationoferk12inhibitorcellulartargetoccupancieswithareversibleslowoffrateprobe
AT heightmantomd quantitationoferk12inhibitorcellulartargetoccupancieswithareversibleslowoffrateprobe